About
Professor Ros Eeles is Professor of Oncogenetics at The Institute of Cancer Research, University of London UK. She trained at The University of Cambridge, UK and St Thomas' Hospital, London. She is a Fellow of the Royal College of Physicians and Royal College of Radiologists (Clinical Oncology Faculty), London UK. She is accredited in Clinical Oncology and has extensive sub-specialist experience in Cancer Genetics.
Professor Eeles' oncological practice is in radiotherapy and chemotherapy for Uro-Oncology. Her cancer genetics practice involves cancer risk assessment, screening advice and management of increased cancer risk in adults for any cancer site. She is also an expert in how the new cancer genetics impacts on treatment decisions. She has edited a specialist textbook on Cancer Prevention and Screening which won the BMA Chairman's award in 2019. She is an author of over 500 original research papers. She has an international standing in Cancer Genetic Clinical Management and research, particularly management of individuals with mutations in the breast/ovarian/prostate cancer predisposition genes, BRCA1, BRCA2 and other genes and genetic predisposition to prostate cancer. She has been on several genetics advisory committees and edited the special edition of Familial Cancer: Cancer Genetics: New Ways of Working which reported on models of delivery of cancer genetics services.
She is a member of the learned societies: ESTRO, ESMO, ASHG, AACR, BAUS, ESHG, ASCO, BSGM and CGG UK
Her outside interests are Opera and Art.
Diseases, Medical Tests and TreatmentsClinical Genetics wrt cancer in adults
Cancer genetics
Prostate Genetics
Clinical genetics wrt cancer genetics in adults
Cancer genetics
Medical genetics
Prostate Genetics
Professor Eeles' oncological practice is in radiotherapy and chemotherapy for Uro-Oncology. Her cancer genetics practice involves cancer risk assessment, screening advice and management of increased cancer risk in adults for any cancer site. She is also an expert in how the new cancer genetics impacts on treatment decisions. She has edited a specialist textbook on Cancer Prevention and Screening which won the BMA Chairman's award in 2019. She is an author of over 500 original research papers. She has an international standing in Cancer Genetic Clinical Management and research, particularly management of individuals with mutations in the breast/ovarian/prostate cancer predisposition genes, BRCA1, BRCA2 and other genes and genetic predisposition to prostate cancer. She has been on several genetics advisory committees and edited the special edition of Familial Cancer: Cancer Genetics: New Ways of Working which reported on models of delivery of cancer genetics services.
She is a member of the learned societies: ESTRO, ESMO, ASHG, AACR, BAUS, ESHG, ASCO, BSGM and CGG UK
Her outside interests are Opera and Art.
Diseases, Medical Tests and TreatmentsClinical Genetics wrt cancer in adults
Cancer genetics
Prostate Genetics
Clinical genetics wrt cancer genetics in adults
Cancer genetics
Medical genetics
Prostate Genetics
“Evidence-based care tailored to each patient — taking the time to explain options and shared decisions.”
— Professor Rosalind Eeles
Education & training
-
2011–2017 MD · Medicine and Surgery
-
2017–2021 Residency · Oncology
-
2021–2022 Fellowship · Subspecialty training
Career & appointments
-
2021-09–2022-08 Junior consultant
Licenses & insurance
Medical licenses
GB — Organización Médica Colegial de España (OMC)
Board certifications
European Board of Oncology
Malpractice insurance:
Allianz Professional · 3,000,000 EUR coverage · No claims on file
Procedures performed
| Procedure | Code | Lifetime count |
|---|---|---|
| GP consultation | 99213 | 2,293 |
| Annual physical exam | 99395 | 91 |
| Vaccination administration | 90471 | 1,155 |
| Minor procedure (skin) | 17110 | 740 |
Services & pricing
| Service | Duration | Modality | Price |
|---|---|---|---|
| New patient consultation (60m) | 60 min | in_clinic|telemed | 180.00 EUR |
| Follow-up consultation (30m) | 30 min | in_clinic|telemed|phone | 90.00 EUR |
| Vaccination administration | 60 min | in_clinic | 630.00 EUR |
| Minor procedure (skin) | 90 min | in_clinic | 720.00 EUR |
Office, team & in practice
Videos
Research & publications
h-index: 15 · i10: 5
-
Outcomes of Oncology in adults — a multi-centre cohort
DOI: 10.4089/euroclin.2025.0 · PMID: 39603241 · cited by 125
-
European registry analysis of Oncology outcomes
DOI: 10.5218/euroclin.2024.1 · PMID: 35056828 · cited by 159
Invited talks
- Practical updates in Oncology European Annual Congress (Oncology) · Vienna · 2024 · invited
- Single-centre experience in Oncology National Society Meeting · London · 2023 · oral abstract
Awards & memberships
Awards
- 🏆 Top-rated Oncology — London · EuroClinics Patient Choice · 2025 · regional
Society memberships
- WONCA Europe — Family Doctors — Member · Since 2022
- national college of family doctors — Member · Since 2022
- European Union of Medical Specialists (UEMS) — Member · Since 2022
Articles by this doctor
- Patient education Patient guide to Oncology
- Awareness When should you see a oncology?
For international patients
- Coordinator
- Patient liaison · professor.rosalind.eeles.2@euroclinics.example
Location
1 tagPatient reviews
Share your experience — help other patients find the right doctor. Write a review →
Recent reviews
-
★★★★★ ✓ Verified Very thorough first visit — explained every step. Booking was easy and the staff were welcoming.
-
★★★★★ ✓ Verified Took time to listen and reviewed all my previous results. I would absolutely recommend.
-
★★★★☆ ✓ Verified Professional and knowledgeable. Wait on the day was a bit long, otherwise excellent.
